Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy.
Romero V, Angeles MA, Rodríguez González E, Cabarrou B, Gil-Moreno A, Pérez-Benavente A, Spagnolo E, Guyon F, Babin G, Bebia V, Luzarraga Aznar A, Bataillon G, Bétrian S, Ferron G, Hernández A, Martinez A.
Romero V, et al. Among authors: spagnolo e.
Int J Gynecol Cancer. 2024 Aug 7:ijgc-2024-005692. doi: 10.1136/ijgc-2024-005692. Online ahead of print.
Int J Gynecol Cancer. 2024.
PMID: 39117375